Cargando…
Melanoma Plasticity: Promoter of Metastasis and Resistance to Therapy
Melanoma is the deadliest form of skin cancer. Although targeted therapies and immunotherapies have revolutionized the treatment of metastatic melanoma, most patients are not cured. Therapy resistance remains a significant clinical challenge. Melanoma comprises phenotypically distinct subpopulations...
Autores principales: | Huang, Fan, Santinon, François, Flores González, Raúl Ernesto, del Rincón, Sonia V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481945/ https://www.ncbi.nlm.nih.gov/pubmed/34604096 http://dx.doi.org/10.3389/fonc.2021.756001 |
Ejemplares similares
-
Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance
por: Ahmed, Farzana, et al.
Publicado: (2018) -
RPS3 Promotes the Metastasis and Cisplatin Resistance of Adenoid Cystic Carcinoma
por: Rui, Xi, et al.
Publicado: (2022) -
Metabolic Plasticity of Melanoma Cells and Their Crosstalk With Tumor Microenvironment
por: Avagliano, Angelica, et al.
Publicado: (2020) -
Tumor microenvironment in non-melanoma skin cancer resistance to photodynamic therapy
por: Cerro, Paulina A., et al.
Publicado: (2022) -
Cellular Phenotype Plasticity in Cancer Dormancy and Metastasis
por: Yang, Xiao, et al.
Publicado: (2018)